Activity Details

Free CME
0.25 AMA PRA Category 1 Credit(s)™
Released: September 4, 2020
Expires: September 4, 2021
15 minutes to complete

Accredited By

Target Audience

This activity is intended for clinical endocrinologists, as well as NPs and PAs working with endocrinologists.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Identify barriers to recognizing and treating severe hypoglycemia
  • Apply clinical guideline recommendations for prevention and treatment of severe hypoglycemia
  • Introduce preemptive strategies to prepare patients/caregivers and improve outcomes in the event of severe hypoglycemic episodes

Activity Description

Dr. Anne Peters presents a patient case and shares her personal approach used in clinical practice. She discusses how to manage fear of hypoglycemia, with a focus on how fear impacts behavior, measuring fear in patients, and preemptive strategies to reduce fear.

Statement of Education Need

Despite an array of advances in diabetes care over the last decade, hypoglycemia remains a common complication of diabetes treatment. Hypoglycemia and the fear of future episodes can be extremely detrimental to quality of life. This activity will review strategies to minimize the risk of hypoglycemia, improve recognition of severe hypoglycemia, and improve guideline adherence to address underutilization of glucagon in patients at risk for level 2 hypoglycemia.


CASE #3: How do I manage fear of hypoglycemia?

  1. Patient case
  2. Barriers to recognizing and treating severe hypoglycemia: difficulty using injectable glucagon
  3. ADA guidelines for hypoglycemia
  4. Preemptive strategies for severe hypoglycemia: patient and caregiver education


Anne Peters, MD
Director, USC Clinical Diabetes Program
Professor of Clinical Medicine
Keck School of Medicine of USC
Los Angeles, CA

Conflict of Interest Policy/Disclosure Statement

The Academy for Continued Healthcare Learning (ACHL) requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation; and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.

The following financial relationships have been provided:
Anne Peters, MD
Sources of Funding for Research: Dexcom, vTv Therapeutics, donated devices from Abbott Diabetes Care
Advisory Board: Abbott Diabetes Care, Boehringer Ingelheim, Eli Lilly and Co., Livongo, MannKind, Merck, Novo Nordisk, Sanofi, Pendulum Therapeutics
Stock Options: Mellitus Health, Livongo, Omada Health, Pendulum Therapeutics, Stability Health
Speakers' Bureau: Novo Nordisk
Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Staff Disclosure
ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

Accreditation Statement

The Academy for Continued Healthcare Learning is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation of Credit

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Receiving Credit

This activity will take approximately 15 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activities, and complete the posttest and evaluation. To receive credit, 66% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

Statement of Commercial Support

Supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit

Disclaimer Statement/Disclosure of Unlabeled Use

The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Contact Information for Questions About the Activity

For questions, contact Melissa Stradal at

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Start Activity

Select your specialty

You must select a specialty

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.